Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance
- 1 August 2002
- journal article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 55 (8) , 833-841
- https://doi.org/10.1016/s0895-4356(02)00437-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspectiveHealth Policy, 2001
- Thrombotic vascular events after change of statinThe Lancet, 1999
- Increased thrombotic vascular events after change of statinThe Lancet, 1998
- Can medical savings accounts for the nonelderly reduce health care costs?Published by American Medical Association (AMA) ,1996
- Identification of Causal Effects Using Instrumental VariablesJournal of the American Statistical Association, 1996
- Ways of measuring rates of recurrent eventsBMJ, 1996
- Why has Patient Compliance become Important?Clinical Research and Regulatory Affairs, 1994
- A chronic disease score from automated pharmacy dataJournal of Clinical Epidemiology, 1992
- Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care.American Journal of Public Health, 1981
- Estimating causal effects of treatments in randomized and nonrandomized studies.Journal of Educational Psychology, 1974